PERCEPTIVE ADVISORS LLC Insider Trading $ALDX Aldeyra Therapeutics, Inc.
Get free email notifications about insider trading for PERCEPTIVE ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is 10% Owner in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in VBI VACCINES INC. ($VBIV) and in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in SCYNEXIS INC ($SCYX) and in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in Athenex, Inc. ($ATNX) and 10% Owner in ALBIREO PHARMA, INC. ($ALBO) and Director in Lyra Therapeutics, Inc. ($LYRA) and 10% Owner in VBI Vaccines Inc/BC ($VBIV) and 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in ADMA BIOLOGICS, INC. ($ADMA) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and 10% Owner in Versartis, Inc. ($VSAR) and in Kadmon Holdings, Inc. ($KDMN) and 10% Owner in Menlo Therapeutics Inc. ($MNLO) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Quotient Ltd ($QTNT) and 10% Owner in Athira Pharma, Inc. ($ATHA) and Director in Athira Pharma, Inc. ($ATHA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Verrica Pharmaceuticals Inc. ($VRCA) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Dova Pharmaceuticals, Inc. ($DOVA) and 10% Owner in Motus GI Holdings, Inc. ($MOTS) and 10% Owner in Prometheus Biosciences, Inc. ($RXDX) and 10% Owner in Rain Therapeutics Inc. ($RAIN) and Director in Solid Biosciences Inc. ($SLDB) and Director in MeiraGTx Holdings plc ($MGTX) and Director in Landos Biopharma, Inc. ($LABP) and Director in ARYA Sciences Acquisition Corp II ($ARYB).
PERCEPTIVE ADVISORS LLC in Aldeyra Therapeutics, Inc.
Trading Symbol: ALDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 8,703,879 shares
Current Value: $43,519,395
Latest Transaction: Jan 21 2021
$ALDX Market Capitalization: $30.29M
$ALDX Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PERCEPTIVE ADVISORS LLC in Aldeyra Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRX, ADMA, AGRX, ALBO, ALDX, FOLD, ARAV, ATNX, ATHA, CATB, CERE, CORI, CRNX, DOVA, GBT, KDMN, LJPC, LABP, LPTX, LYRA, MGTX, MOTS, RXDX, QTNT, RAIN, SCYX, SLDB, VBIV, VBIV, VRCA, MNLO, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 21 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 9.50 | 1,368,421 | 13,000,000 | 8,703,879 | 7.3 M to 8.7 M (+18.65 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.60 | 50,000 | 380,000 | 7,335,458 | 7.3 M to 7.3 M (+0.69 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 10.21 | 152,668 | 1,558,740 | 7,285,458 | 7.1 M to 7.3 M (+2.14 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 9.21 | 347,332 | 3,198,928 | 7,132,790 | 6.8 M to 7.1 M (+5.12 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 8.13 | 500,000 | 4,065,000 | 6,785,458 | 6.3 M to 6.8 M (+7.95 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.60 | 50,000 | 380,000 | 7,335,458 | 7.3 M to 7.3 M (+0.69 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 10.21 | 152,668 | 1,558,740 | 7,285,458 | 7.1 M to 7.3 M (+2.14 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 9.21 | 347,332 | 3,198,928 | 7,132,790 | 6.8 M to 7.1 M (+5.12 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 8.13 | 500,000 | 4,065,000 | 6,785,458 | 6.3 M to 6.8 M (+7.95 %) |
Jul 13 2020 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.25 | 3,200,000 | 13,600,000 | 6,285,458 | 3.1 M to 6.3 M (+103.71 %) |
Sep 21 2017 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.25 | 200,000 | 1,450,000 | 3,085,458 | 2.9 M to 3.1 M (+6.93 %) |
Feb 15 2017 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.50 | 893,025 | 4,018,613 | 2,589,451 | 1.7 M to 2.6 M (+52.64 %) |
May 26 2016 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 700,000 | 3,500,000 | 1,940,458 | 1.2 M to 1.9 M (+56.43 %) |
Nov 05 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.50 | 45,100 | 293,150 | 1,240,458 | 1.2 M to 1.2 M (+3.77 %) |
Oct 28 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.46 | 50,000 | 323,150 | 1,195,358 | 1.1 M to 1.2 M (+4.37 %) |
Oct 26 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.47 | 18,020 | 116,661 | 1,145,358 | 1.1 M to 1.1 M (+1.60 %) |
Oct 22 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.44 | 22,797 | 146,858 | 1,127,338 | 1.1 M to 1.1 M (+2.06 %) |
Oct 22 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.30 | 14,348 | 90,335 | 1,104,541 | 1.1 M to 1.1 M (+1.32 %) |
Page: 1